Search results | supply

Reports

Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics

The Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the manufacturing and supply agreements entered into by the worlds leading biopharma companies.

Hematology Partnering Terms and Agreements

The Hematology Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the hematology partnering deals and agreements entered into by the worlds leading healthcare companies.

Trends in Therapeutic Partnering

The Trends in Therapeutic Partnering report provides the most comprehensive and in-depth insight into the 35 most popular therapeutic targets for partnering in the period 2009 to mid 2014.

Molecular Diagnostics Partnering Terms and Agreements

The Molecular Diagnostics Partnering Terms and Agreements report provides a detailed understanding and analysis of how and why companies enter molecular diagnostics partnering deals.

Diagnostic Imaging Partnering Terms and Agreements

The Diagnostic Imaging Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the diagnostic imaging partnering agreements entered into by the worlds leading healthcare companies.

Antibiotics Partnering Terms and Agreements

The Antibiotics Partnering Agreements report provides an understanding and access to the antibiotics partnering deals and agreements entered into by the worlds leading healthcare companies.   Trends in antibiotics partnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Antibiotics partnering contract documents Top antibiotics deals by value   The Antibiotics Partnering Terms and more »

Orphan Diseases Partnering Terms and Agreements

The Orphan Diseases Partnering Terms and Agreements report provides an understanding and access to the orphan diseases partnering deals and agreements entered into by the worlds leading healthcare companies.   Trends in orphan diseases partnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Orphan diseases partnering contract documents Top orphan diseases deals more »

Gene Therapy Partnering Terms and Agreements

The Gene Therapy Partnering Agreements report provides an understanding and access to the gene therapy partnering deals and agreements entered into by the worlds leading healthcare companies.

Infectious Vaccines Partnering Terms and Agreements

The Infectious Vaccines Partnering Terms and Agreements report provides a detailed understanding and analysis of how and why companies enter infectious vaccines partnering deals.

Cancer Diagnostics Partnering Terms and Agreements

The Cancer Diagnostics Partnering Agreements report provides an understanding and access to the cancer diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies.   Trends in cancer diagnostics partnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Cancer diagnostics partnering contract documents Top cancer diagnostics deals by value   The more »

Insights

Manufacturing and Supply partnering: global trends in pharma industry

The article here analyses the recent manufacturing and supply partnering trends in the pharma industry. A supply or manufacturing agreement is normally between a product manufacturer and product owner in which an owner outsources the manufacture and supply of its product(s) to the service company in a defined territory.

Supply

Supply is the provision of goods for use or sale in response to a request or demand for the goods

Grifols: Keeping the world’s blood supply pumping

Grifols is a Spanish global pharmaceutical company specialising in the supply of blood plasma products.

Manufacturing and supply agreements: recent life sciences partnering deal trends

Manufacturing and supply agreements have long been present in the pharmaceutical industry, as companies have sought external expertise for manufacturing and supply of finished product.

Pfizer outlines its supply strategy

By Patricia Van Arnum. John Kelly, Vice President of strategy and transitioning sites for Pfizer Global Supply, discusses the company’s manufacturing and supply strategy and network. 

Stocks of smallpox anti-virals sore with $2.8bn supply contract

US Department of Health and Human Services (HHS) has awarded a contract to SIGA Technologies for 1.7 million courses of smallpox antivirals to combat bio-warfare pathogens.

Charles River Laboratories hunts for M&A

M&A hunt: Speaking at the Leerink Swann Global Healthcare Conference last week, James Foster, chief executive officer of Charles River Laboratories, indicated the company was actively looking for merger and acquisition targets in 2015.

M&A news: who will win the bidding race?

M&A news: The Canadian pharma company Valeant Pharmaceuticals is rumoured to be raising money to make a bid for specialty drugmaker Salix Pharmaceuticals, according to Bloomberg, which cites people familiar with the matter.

Current Agreements Deal Analysis Update : November 2014

This month we provide you with an overview of deal analysis in the life science sectors, covering partnering, M&A and financing in October 2014.

Pharmacyclics: Partnering activity 2009-2014

Pharmacyclics, listed as a new big biotech entrant in 2014, works to improve the lives of cancer affected patients by entering into strategic partnering deals to support its product pipeline.

Events

Sorry, your search returned no results.


Deals

Manufacturing and supply agreement for gene expression assays

HTG Molecular Diagnostics and OvaGene Oncology have entered a manufacturing supply agreement where OvaGene will design and develop their proprietary gene expression assays on HTG’s fully automated, extraction-free Edge Platform.

Biotech deal for $515 million for supply agreement

Varian Medical Systems signed a biotech deal for 3 year supply agreement. 

Supply agreement between Arena Pharmaceutical and Eisai

Arena and Eisai have entered into a marketing and supply agreement for  $1.796 billion, if all option are exercised. 

The Proton Therapy Center biotech deals Provision Healthcare for RayStation supply

RaySearch Laboratories has entered biotech deals for its RayStation treatment planning system with Provision Center for Proton Therapy.

AstraZeneca big pharma deals Myriad Genetics for companion diagnostics supply

Myriad Genetics has entered into expanded, non-exclusive global pharma deals with AstraZeneca to provide companion diagnostics for the olaparib Phase 3 clinical development program.

Pfizer big pharma deals with Abcam for biological compound supply and licensing

Abcam pharma deals with Pfizer, a big company, entering into a supply and licensing agreement for biological compounds.

AstraZeneca big pharma deals Par Pharmaceutical for Atacand supply and distribution

AstraZeneca enters big pharma deals with Par Pharmaceutical Companies for an exclusive U.S. supply and distribution agreement in which Par will distribute the authorized generic version of AstraZeneca’s Atacand.

Big pharma Mylan announces supply of antiretroviral drugs to NACO in India

Mylan, a top big pharma announced that its India-based subsidiary Mylan Laboratories Limited has been selected as a leading supplier of antiretroviral drugs to India’s National AIDS Control Organization .

AmerisourceBergen signs $18.5 billion pharma deals supply agreement with Express Scripts

AmerisourceBergen Corporation has signed a three year pharma deals agreement to supply approximately $18.5 billion in pharmaceuticals to Express Scripts on an annual basis.

Big pharma Otsuka pharma partners Catalent to supply OD tablets

Following a pharma partners agreement, Catalent has commenced supply to big pharma, Otsuka Pharmaceutical of Abilify OD Tablets which utilize Catalent’s Zydis fast dissolve drug delivery technology.